Precision BioSciences (DTIL) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/08/22
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 08/08/22
Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022Business Wire • 08/01/22
All You Need to Know About Precision BioSciences (DTIL) Rating Upgrade to Strong BuyZacks Investment Research • 07/21/22
Precision BioSciences Announces Closing of Underwritten Offering of Common StockBusiness Wire • 06/27/22
Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell DiseaseBusiness Wire • 06/21/22
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate for CAR T Relapsed Patient PopulationBusiness Wire • 06/08/22
Precision BioSciences to Provide an Update on its Ongoing Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on Wednesday, June 8, 2022Business Wire • 06/03/22
Precision BioSciences to Participate in Upcoming Jefferies Healthcare ConferenceBusiness Wire • 06/03/22
Precision BioSciences Announces Publication in Molecular Therapy of ARCUS® In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B InfectionBusiness Wire • 05/18/22
Precision BioSciences Announces Preclinical Data Showcasing Premier In Vivo Gene Editing Capabilities at American Society of Gene & Cell Therapy Annual MeetingBusiness Wire • 05/16/22
Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/22
Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 05/09/22
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Society of Gene & Cell Therapy 25th Annual MeetingBusiness Wire • 05/02/22
Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022Business Wire • 05/02/22
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business UpdateBusiness Wire • 03/15/22